✦ LIBER ✦

Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicin

✍ Scribed by Tsunefumi Shibuya; Takanori Teshima; Mine Harada; Shuichi Taniguchi; Takashi Okamura; Sei-Ichi Okamura; Yoshiyuki Niho

Book ID: 113239189
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 396 KB
Volume: 14
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(90)90045-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase II trial of low-dose

A randomized phase II trial of low-dose aclarubicin vs very low-dose cytosine arabinoside for treatment of myelodysplastic syndromes

✍ Mine Harada; Tsunefumi Shibuya; Takanori Teshima; Masahiro Murakawa; Takashi Oka 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Low dose arabinosyl cytosine for treatme

Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia

✍ Michele Baccarani; Alfonso Zaccaria; Giuseppe Bandini; Giovanna Cavazzini; Renat 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine

✍ Spitzer, Thomas R. ;Lazarus, Hillard M. ;Crum, Edward D. ;Weisman, Russell 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Several cytotoxic agents when used in vitro in very low concentrations have been shown to induce differentiation of leukemic cells. We treated 18 patients with rnyelodysplastic syndromes with lowdose oral 6-thioguanine (6-TG; 20 to 60 rng daily). Four patients demonstrated significant improvement in

Treatment with low-dose oral etoposide i

Treatment with low-dose oral etoposide in patients with myelodysplastic syndromes

✍ Donald C. Doll; Lawrence M. Kasper; Raymond Taetle; Alan F. List 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 560 KB

Low-dose cytosine-arabinoside in the tre

Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

✍ Weh, H. J. ;Zschaber, R. ;Hossfeld, D. K. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 189 KB

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre